Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Decongestant Market Growth 2022-2028

  • LP 4821454
  • 95 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Decongestant will have significant change from previous year. According to our (LP Information) latest study, the global Decongestant market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Decongestant market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Decongestant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Decongestant market, reaching US$ million by the year 2028. As for the Europe Decongestant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Decongestant players cover Mylan N.V., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Beximco Pharmaceuticals Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Decongestant market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tablets

Capsules

Nasal Sprays

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Research & Academic Laboratories

Clinic

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Mylan N.V.

Teva Pharmaceutical Industries Ltd.

Ranbaxy Laboratories Ltd.

Beximco Pharmaceuticals Ltd.

Novartis AG

Cipla Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Decongestant Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Decongestant by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Decongestant by Country/Region, 2017, 2022 & 2028

2.2 Decongestant Segment by Type

2.2.1 Tablets

2.2.2 Capsules

2.2.3 Nasal Sprays

2.3 Decongestant Sales by Type

2.3.1 Global Decongestant Sales Market Share by Type (2017-2022)

2.3.2 Global Decongestant Revenue and Market Share by Type (2017-2022)

2.3.3 Global Decongestant Sale Price by Type (2017-2022)

2.4 Decongestant Segment by Application

2.4.1 Hospitals

2.4.2 Research & Academic Laboratories

2.4.3 Clinic

2.4.4 Other

2.5 Decongestant Sales by Application

2.5.1 Global Decongestant Sale Market Share by Application (2017-2022)

2.5.2 Global Decongestant Revenue and Market Share by Application (2017-2022)

2.5.3 Global Decongestant Sale Price by Application (2017-2022)

3 Global Decongestant by Company

3.1 Global Decongestant Breakdown Data by Company

3.1.1 Global Decongestant Annual Sales by Company (2020-2022)

3.1.2 Global Decongestant Sales Market Share by Company (2020-2022)

3.2 Global Decongestant Annual Revenue by Company (2020-2022)

3.2.1 Global Decongestant Revenue by Company (2020-2022)

3.2.2 Global Decongestant Revenue Market Share by Company (2020-2022)

3.3 Global Decongestant Sale Price by Company

3.4 Key Manufacturers Decongestant Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Decongestant Product Location Distribution

3.4.2 Players Decongestant Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Decongestant by Geographic Region

4.1 World Historic Decongestant Market Size by Geographic Region (2017-2022)

4.1.1 Global Decongestant Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Decongestant Annual Revenue by Geographic Region

4.2 World Historic Decongestant Market Size by Country/Region (2017-2022)

4.2.1 Global Decongestant Annual Sales by Country/Region (2017-2022)

4.2.2 Global Decongestant Annual Revenue by Country/Region

4.3 Americas Decongestant Sales Growth

4.4 APAC Decongestant Sales Growth

4.5 Europe Decongestant Sales Growth

4.6 Middle East & Africa Decongestant Sales Growth

5 Americas

5.1 Americas Decongestant Sales by Country

5.1.1 Americas Decongestant Sales by Country (2017-2022)

5.1.2 Americas Decongestant Revenue by Country (2017-2022)

5.2 Americas Decongestant Sales by Type

5.3 Americas Decongestant Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Decongestant Sales by Region

6.1.1 APAC Decongestant Sales by Region (2017-2022)

6.1.2 APAC Decongestant Revenue by Region (2017-2022)

6.2 APAC Decongestant Sales by Type

6.3 APAC Decongestant Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Decongestant by Country

7.1.1 Europe Decongestant Sales by Country (2017-2022)

7.1.2 Europe Decongestant Revenue by Country (2017-2022)

7.2 Europe Decongestant Sales by Type

7.3 Europe Decongestant Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Decongestant by Country

8.1.1 Middle East & Africa Decongestant Sales by Country (2017-2022)

8.1.2 Middle East & Africa Decongestant Revenue by Country (2017-2022)

8.2 Middle East & Africa Decongestant Sales by Type

8.3 Middle East & Africa Decongestant Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Decongestant

10.3 Manufacturing Process Analysis of Decongestant

10.4 Industry Chain Structure of Decongestant

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Decongestant Distributors

11.3 Decongestant Customer

12 World Forecast Review for Decongestant by Geographic Region

12.1 Global Decongestant Market Size Forecast by Region

12.1.1 Global Decongestant Forecast by Region (2023-2028)

12.1.2 Global Decongestant Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Decongestant Forecast by Type

12.7 Global Decongestant Forecast by Application

13 Key Players Analysis

13.1 Mylan N.V.

13.1.1 Mylan N.V. Company Information

13.1.2 Mylan N.V. Decongestant Product Offered

13.1.3 Mylan N.V. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Mylan N.V. Main Business Overview

13.1.5 Mylan N.V. Latest Developments

13.2 Teva Pharmaceutical Industries Ltd.

13.2.1 Teva Pharmaceutical Industries Ltd. Company Information

13.2.2 Teva Pharmaceutical Industries Ltd. Decongestant Product Offered

13.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.2.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.3 Ranbaxy Laboratories Ltd.

13.3.1 Ranbaxy Laboratories Ltd. Company Information

13.3.2 Ranbaxy Laboratories Ltd. Decongestant Product Offered

13.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ranbaxy Laboratories Ltd. Main Business Overview

13.3.5 Ranbaxy Laboratories Ltd. Latest Developments

13.4 Beximco Pharmaceuticals Ltd.

13.4.1 Beximco Pharmaceuticals Ltd. Company Information

13.4.2 Beximco Pharmaceuticals Ltd. Decongestant Product Offered

13.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Beximco Pharmaceuticals Ltd. Main Business Overview

13.4.5 Beximco Pharmaceuticals Ltd. Latest Developments

13.5 Novartis AG

13.5.1 Novartis AG Company Information

13.5.2 Novartis AG Decongestant Product Offered

13.5.3 Novartis AG Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis AG Main Business Overview

13.5.5 Novartis AG Latest Developments

13.6 Cipla Ltd.

13.6.1 Cipla Ltd. Company Information

13.6.2 Cipla Ltd. Decongestant Product Offered

13.6.3 Cipla Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Cipla Ltd. Main Business Overview

13.6.5 Cipla Ltd. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Decongestant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Decongestant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Capsules

Table 5. Major Players of Nasal Sprays

Table 6. Global Decongestant Sales by Type (2017-2022) & (MT)

Table 7. Global Decongestant Sales Market Share by Type (2017-2022)

Table 8. Global Decongestant Revenue by Type (2017-2022) & ($ million)

Table 9. Global Decongestant Revenue Market Share by Type (2017-2022)

Table 10. Global Decongestant Sale Price by Type (2017-2022) & (USD/Kg)

Table 11. Global Decongestant Sales by Application (2017-2022) & (MT)

Table 12. Global Decongestant Sales Market Share by Application (2017-2022)

Table 13. Global Decongestant Revenue by Application (2017-2022)

Table 14. Global Decongestant Revenue Market Share by Application (2017-2022)

Table 15. Global Decongestant Sale Price by Application (2017-2022) & (USD/Kg)

Table 16. Global Decongestant Sales by Company (2020-2022) & (MT)

Table 17. Global Decongestant Sales Market Share by Company (2020-2022)

Table 18. Global Decongestant Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Decongestant Revenue Market Share by Company (2020-2022)

Table 20. Global Decongestant Sale Price by Company (2020-2022) & (USD/Kg)

Table 21. Key Manufacturers Decongestant Producing Area Distribution and Sales Area

Table 22. Players Decongestant Products Offered

Table 23. Decongestant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Decongestant Sales by Geographic Region (2017-2022) & (MT)

Table 27. Global Decongestant Sales Market Share Geographic Region (2017-2022)

Table 28. Global Decongestant Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Decongestant Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Decongestant Sales by Country/Region (2017-2022) & (MT)

Table 31. Global Decongestant Sales Market Share by Country/Region (2017-2022)

Table 32. Global Decongestant Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Decongestant Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Decongestant Sales by Country (2017-2022) & (MT)

Table 35. Americas Decongestant Sales Market Share by Country (2017-2022)

Table 36. Americas Decongestant Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Decongestant Revenue Market Share by Country (2017-2022)

Table 38. Americas Decongestant Sales by Type (2017-2022) & (MT)

Table 39. Americas Decongestant Sales Market Share by Type (2017-2022)

Table 40. Americas Decongestant Sales by Application (2017-2022) & (MT)

Table 41. Americas Decongestant Sales Market Share by Application (2017-2022)

Table 42. APAC Decongestant Sales by Region (2017-2022) & (MT)

Table 43. APAC Decongestant Sales Market Share by Region (2017-2022)

Table 44. APAC Decongestant Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Decongestant Revenue Market Share by Region (2017-2022)

Table 46. APAC Decongestant Sales by Type (2017-2022) & (MT)

Table 47. APAC Decongestant Sales Market Share by Type (2017-2022)

Table 48. APAC Decongestant Sales by Application (2017-2022) & (MT)

Table 49. APAC Decongestant Sales Market Share by Application (2017-2022)

Table 50. Europe Decongestant Sales by Country (2017-2022) & (MT)

Table 51. Europe Decongestant Sales Market Share by Country (2017-2022)

Table 52. Europe Decongestant Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Decongestant Revenue Market Share by Country (2017-2022)

Table 54. Europe Decongestant Sales by Type (2017-2022) & (MT)

Table 55. Europe Decongestant Sales Market Share by Type (2017-2022)

Table 56. Europe Decongestant Sales by Application (2017-2022) & (MT)

Table 57. Europe Decongestant Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Decongestant Sales by Country (2017-2022) & (MT)

Table 59. Middle East & Africa Decongestant Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Decongestant Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Decongestant Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Decongestant Sales by Type (2017-2022) & (MT)

Table 63. Middle East & Africa Decongestant Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Decongestant Sales by Application (2017-2022) & (MT)

Table 65. Middle East & Africa Decongestant Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Decongestant

Table 67. Key Market Challenges & Risks of Decongestant

Table 68. Key Industry Trends of Decongestant

Table 69. Decongestant Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Decongestant Distributors List

Table 72. Decongestant Customer List

Table 73. Global Decongestant Sales Forecast by Region (2023-2028) & (MT)

Table 74. Global Decongestant Sales Market Forecast by Region

Table 75. Global Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Decongestant Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Decongestant Sales Forecast by Country (2023-2028) & (MT)

Table 78. Americas Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Decongestant Sales Forecast by Region (2023-2028) & (MT)

Table 80. APAC Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Decongestant Sales Forecast by Country (2023-2028) & (MT)

Table 82. Europe Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Decongestant Sales Forecast by Country (2023-2028) & (MT)

Table 84. Middle East & Africa Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Decongestant Sales Forecast by Type (2023-2028) & (MT)

Table 86. Global Decongestant Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Decongestant Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Decongestant Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Decongestant Sales Forecast by Application (2023-2028) & (MT)

Table 90. Global Decongestant Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Decongestant Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Decongestant Revenue Market Share Forecast by Application (2023-2028)

Table 93. Mylan N.V. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 94. Mylan N.V. Decongestant Product Offered

Table 95. Mylan N.V. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 96. Mylan N.V. Main Business

Table 97. Mylan N.V. Latest Developments

Table 98. Teva Pharmaceutical Industries Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 99. Teva Pharmaceutical Industries Ltd. Decongestant Product Offered

Table 100. Teva Pharmaceutical Industries Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 101. Teva Pharmaceutical Industries Ltd. Main Business

Table 102. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 103. Ranbaxy Laboratories Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 104. Ranbaxy Laboratories Ltd. Decongestant Product Offered

Table 105. Ranbaxy Laboratories Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 106. Ranbaxy Laboratories Ltd. Main Business

Table 107. Ranbaxy Laboratories Ltd. Latest Developments

Table 108. Beximco Pharmaceuticals Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 109. Beximco Pharmaceuticals Ltd. Decongestant Product Offered

Table 110. Beximco Pharmaceuticals Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 111. Beximco Pharmaceuticals Ltd. Main Business

Table 112. Beximco Pharmaceuticals Ltd. Latest Developments

Table 113. Novartis AG Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 114. Novartis AG Decongestant Product Offered

Table 115. Novartis AG Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 116. Novartis AG Main Business

Table 117. Novartis AG Latest Developments

Table 118. Cipla Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors

Table 119. Cipla Ltd. Decongestant Product Offered

Table 120. Cipla Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 121. Cipla Ltd. Main Business

Table 122. Cipla Ltd. Latest Developments

List of Figures

Figure 1. Picture of Decongestant

Figure 2. Decongestant Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Decongestant Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Decongestant Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Decongestant Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Capsules

Figure 11. Product Picture of Nasal Sprays

Figure 12. Global Decongestant Sales Market Share by Type in 2021

Figure 13. Global Decongestant Revenue Market Share by Type (2017-2022)

Figure 14. Decongestant Consumed in Hospitals

Figure 15. Global Decongestant Market: Hospitals (2017-2022) & (MT)

Figure 16. Decongestant Consumed in Research & Academic Laboratories

Figure 17. Global Decongestant Market: Research & Academic Laboratories (2017-2022) & (MT)

Figure 18. Decongestant Consumed in Clinic

Figure 19. Global Decongestant Market: Clinic (2017-2022) & (MT)

Figure 20. Decongestant Consumed in Other

Figure 21. Global Decongestant Market: Other (2017-2022) & (MT)

Figure 22. Global Decongestant Sales Market Share by Application (2017-2022)

Figure 23. Global Decongestant Revenue Market Share by Application in 2021

Figure 24. Decongestant Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Decongestant Revenue Market Share by Company in 2021

Figure 26. Global Decongestant Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Decongestant Revenue Market Share by Geographic Region in 2021

Figure 28. Global Decongestant Sales Market Share by Region (2017-2022)

Figure 29. Global Decongestant Revenue Market Share by Country/Region in 2021

Figure 30. Americas Decongestant Sales 2017-2022 (MT)

Figure 31. Americas Decongestant Revenue 2017-2022 ($ Millions)

Figure 32. APAC Decongestant Sales 2017-2022 (MT)

Figure 33. APAC Decongestant Revenue 2017-2022 ($ Millions)

Figure 34. Europe Decongestant Sales 2017-2022 (MT)

Figure 35. Europe Decongestant Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Decongestant Sales 2017-2022 (MT)

Figure 37. Middle East & Africa Decongestant Revenue 2017-2022 ($ Millions)

Figure 38. Americas Decongestant Sales Market Share by Country in 2021

Figure 39. Americas Decongestant Revenue Market Share by Country in 2021

Figure 40. United States Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Decongestant Sales Market Share by Region in 2021

Figure 45. APAC Decongestant Revenue Market Share by Regions in 2021

Figure 46. China Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Decongestant Sales Market Share by Country in 2021

Figure 53. Europe Decongestant Revenue Market Share by Country in 2021

Figure 54. Germany Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Decongestant Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Decongestant Revenue Market Share by Country in 2021

Figure 61. Egypt Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Decongestant Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Decongestant in 2021

Figure 67. Manufacturing Process Analysis of Decongestant

Figure 68. Industry Chain Structure of Decongestant

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390